2008
DOI: 10.1212/01.wnl.0000299387.59159.db
|View full text |Cite
|
Sign up to set email alerts
|

CLINICOPATHOLOGIC STUDY OF A SNCA GENE DUPLICATION PATIENT WITH PARKINSON DISEASE AND DEMENTIA

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
49
1

Year Published

2008
2008
2014
2014

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 79 publications
(55 citation statements)
references
References 9 publications
5
49
1
Order By: Relevance
“…It is sometimes associated with tauopathy [10] that resembles argyrophilic grain disease, a medial temporal tauopathy that increases in frequency with age [11] and can also present with amnestic mild cognitive impairment [12] . Focal neuronal loss and gliosis in the hippocampus can be seen in other degenerative disorders, such as Lewy body disease, but the distribution is different, being most severe in CA2/3 [13,14] .…”
Section: Introductionmentioning
confidence: 99%
“…It is sometimes associated with tauopathy [10] that resembles argyrophilic grain disease, a medial temporal tauopathy that increases in frequency with age [11] and can also present with amnestic mild cognitive impairment [12] . Focal neuronal loss and gliosis in the hippocampus can be seen in other degenerative disorders, such as Lewy body disease, but the distribution is different, being most severe in CA2/3 [13,14] .…”
Section: Introductionmentioning
confidence: 99%
“…The subsequent identification of SNCA locus duplications lead to the additional observations of whole-gene duplications and triplications of variable genomic lengths [Chartier-Harlin et al, 2004;Farrer et al, 2004;Fuchs et al, 2007;Ibanez et al, 2004;Ikeuchi et al, 2008;Nishioka et al, 2006;Obi et al, 2008]. There was, however, no evidence that overexpression of other genes located in the repeated regions contributed to the PD phenotype in duplication or triplication carriers .…”
Section: Introductionmentioning
confidence: 99%
“…There was, however, no evidence that overexpression of other genes located in the repeated regions contributed to the PD phenotype in duplication or triplication carriers . Most studies showed that SNCA dosage influenced clinical expression of PD, with PD with dementia (PDD) being more common in SNCA duplication carriers and dementia with Lewy bodies (DLB) in SNCA triplication carriers [Chartier-Harlin et al, 2004;Farrer et al, 2004;Fuchs et al, 2007;Ibanez et al, 2004;Ikeuchi et al, 2008;Nishioka et al, 2006;Obi et al, 2008].…”
Section: Introductionmentioning
confidence: 99%
“…One patient presented with a severe clinical course with no efficacy for levodopa therapy. He progressed to Hoehn and Yahr stage V in a few years and at autopsy demonstrated features similar to DLB (Obi et al, 2008). In addition, we also detected five asymptomatic carriers over 65 years old.…”
Section: Snca Triplication and Duplication In Hereditary Pdmentioning
confidence: 52%